health
TAR-Targeting CRISPR-Cas13X Suppressed HIV-1 Reactivation in Lab Models
A bioRxiv preprint reports that CRISPR-Cas13X.1 targeting the HIV-1 TAR RNA element reduced viral gene expression and reactivation in laboratory models. The findings include experiments in HIV-infected primary immune cells, but are preclinical.